Health2047 Inc., the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA), has spun out portfolio company SiteBridge Research, Inc., which seeks to make clinical trials more accessible by empowering a broader set of physicians and their patients to take part in research though its novel 'Trial-In-A-Box' platform. SiteBridge Research (SiteBridge) is creating a sustainable path towards enriched real-world data (RWD) and real-world evidence (RWE), resulting in more widely applicable clinical trial results. This approach will accelerate the time to market and ultimately product adoption in communities that are harder to reach and have some of the highest unmet needs.
"We're excited by SiteBridge Research's mission to democratize clinical trials by opening access and removing barriers to different parts of the clinical trial ecosystem,"-Lawrence K. Cohen, CEO of Health2047.
コメント